CUROSURF® (poractant alfa) Intratracheal Suspension is indicated for the rescue treatment of Respiratory Distress Syndrome (RDS) in premature infants. CUROSURF reduces mortality and pneumothoraces associated with RDS.
Curosurf Injection 80 mg/mL 1 Vialx1.5 mL works by reducing the surface tension within the alveoli of the lungs and improves breathing.
Reviews
There are no reviews yet